Literature DB >> 11693537

Effects of 6-arylamino-5,8-quinolinediones and 6-chloro-7-arylamino-5,8-isoquinolinediones on NAD(P)H: quinone oxidoreductase (NQO1) activity and their cytotoxic potential.

C K Ryu1, H J Jeong, S K Lee, H J You, K U Choi, J Y Shim, Y H Heo, C O Lee.   

Abstract

Synthesized 6-arylamino-5,8-quinolinediones 4a-4j and 6-chloro-7-arylamino-5,8-isoquinolinediones 5a-5g were evaluated for effects on NAD(P)H: quinone oxidoreductase (NQO1) activity with the cytosolic fractions derived from cultured human lung cancer cells and their cytotoxicity in cultured several human solid cancer cell lines. The 5,8-quinolinediones 4 and 5,8-isoquinolinediones 5 affected the reduction potential by NQO1 activity and showed a potent cytotoxic activity against human cancer cell lines. The tested compounds 4a, 5c, 5f, and 5g were considered as more potent cytotoxic agents. The compounds 4d, 5b, 5c, 5e and 5g were comparable modulators of NQO1 activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11693537     DOI: 10.1007/bf02975181

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  3 in total

1.  Half-Wave Potentials and In Vitro Cytotoxic Evaluation of 3-Acylated 2,5-Bis(phenylamino)-1,4-benzoquinones on Cancer Cells.

Authors:  Julio Benites; Jaime A Valderrama; Maryan Ramos; Maudy Valenzuela; Angélica Guerrero-Castilla; Giulio G Muccioli; Pedro Buc Calderon
Journal:  Molecules       Date:  2019-05-08       Impact factor: 4.411

Review 2.  5,8-Quinolinedione Scaffold as a Promising Moiety of Bioactive Agents.

Authors:  Monika Kadela-Tomanek; Ewa Bębenek; Elwira Chrobak; Stanisław Boryczka
Journal:  Molecules       Date:  2019-11-14       Impact factor: 4.411

3.  Hybrids of 1,4-Quinone with Quinoline Derivatives: Synthesis, Biological Activity, and Molecular Docking with DT-Diaphorase (NQO1).

Authors:  Monika Kadela-Tomanek; Maria Jastrzębska; Elwira Chrobak; Ewa Bębenek; Małgorzata Latocha
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.